Life Sciences Greenhouse Investments — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Avisi Technologies develops nanotechnology-enabled implantable devices to lower intraocular pressure in patients with open-angle glaucoma.
Deep TechHealthtechMedical DevicesPhiladelphia, US
Rui Jing Jiang(Ms. Jiang is the Chief Executive Officer of the Issuer.)inPaul Norris(Director)inBrandon Kao(Director)inGary Pruden(Director)in
BoardCatherine Mohr(Director)in
Co-investorsMedVenture Partners, Inc.GaingelsGolden SeedsGood Growth Capital
sovaSage develops technology that optimizes the CPAP mask-fitting process for sleep apnea patients.
AI & Machine LearningHealthtechMedical DevicesCentral City, US
William Kaigler(Executive Officer, Director)inDavid Mawhinney(Director)Christian Kebekus(Executive Officer, Director)Julie Kaigler(Executive Officer)
Co-investors412 Venture FundRiverfront Ventures, LLC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



__Twitter.png)



